Cargando…

429 Eribulin Synergizes with STING Agonists by Enhancing Type 1 Interferon Expression and Improves Antitumor Efficacy as Combination Treatment

OBJECTIVES/GOALS: Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks effective targeted treatment options. TNBC's greater degree of immunogenicity than other breast tumors makes immunotherapy a viable strategy. Strategies to improve the immunotherapy response includes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi-Ruiz, Leila, Fermaintt, Charles S., Wilkinson, Nancy, Chan, Peter Y., Mooberry, Susan L., Risinger, April L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Team Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129478/ http://dx.doi.org/10.1017/cts.2023.460

Ejemplares similares

The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2022)

Eribulin Activates the cGAS-STING Pathway via the Cytoplasmic Accumulation of Mitochondrial DNA
por: Fermaintt, Charles S., et al.
Publicado: (2021)

Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent manner
por: Kaul, Roma, et al.
Publicado: (2019)

Correction: Eribulin rapidly inhibits TGF-β-induced Snail expression and can induce Slug expression in a Smad4-dependent manner
por: Kaul, Roma, et al.
Publicado: (2020)

Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130Cas/Src inhibition by eribulin
por: Dybdal-Hargreaves, Nicholas F., et al.
Publicado: (2017)

Correction: Regulation of E-cadherin localization by microtubule targeting agents: rapid promotion of cortical E-cadherin through p130CAS/Src inhibition by eribulin
por: Dybdal-Hargreaves, Nicholas F., et al.
Publicado: (2019)

Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential
por: Fermaintt, Charles S., et al.
Publicado: (2021)

39901 Breaking down silos to synergize clinical trial development and initiation: The Clinical Research Support Center, University of Minnesota
por: Odlaug, Brian L., et al.
Publicado: (2021)

In Vivo Evaluation of (−)-Zampanolide Demonstrates Potent and Persistent Antitumor Efficacy When Targeted to the Tumor Site
por: Takahashi-Ruiz, Leila, et al.
Publicado: (2022)

Synthetic Reactions with Rare Taccalonolides Reveal the Value of C-22,23 Epoxidation for Microtubule Stabilizing Potency
por: Peng, Jiangnan, et al.
Publicado: (2014)

Eribulin and Paclitaxel Differentially Alter Extracellular Vesicles and Their Cargo from Triple-Negative Breast Cancer Cells
por: Pederson, Petra J., et al.
Publicado: (2021)

Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
por: Lemos, Henrique, et al.
Publicado: (2020)

Identification of MSA-2: An oral antitumor non-nucleotide STING agonist
por: Liu, Jianhua, et al.
Publicado: (2021)

An inhalable nanoparticulate STING agonist synergizes with radiotherapy to confer long-term control of lung metastases
por: Liu, Yang, et al.
Publicado: (2019)

46733 Strategy for Effective Team Formation: A Case Study of Rutgers’ Big Ideas Initiative
por: Razeq, Ziyad, et al.
Publicado: (2021)

54478 The NIH Reporter Database: A Wealth of Information for Developing Team Science Metrics?
por: Arman, Hosen, et al.
Publicado: (2021)

27229 Team Science: A Two-Year Follow-Up Case Study of Rutgers’ Ideation Forum
por: Arman, Hosen, et al.
Publicado: (2021)

TAK-676: A Novel Stimulator of Interferon Genes (STING) Agonist Promoting Durable IFN-dependent Antitumor Immunity in Preclinical Studies
por: Carideo Cunniff, Elizabeth, et al.
Publicado: (2022)

Eribulin mesylate exerts antitumor effects via CD103
por: Oya, Kazumasa, et al.
Publicado: (2023)

Liposome-Encapsulated Eribulin Shows Enhanced Antitumor Activity over Eribulin for Combination Therapy with Anti–PD-1 Antibody
por: Niwa, Yuki, et al.
Publicado: (2023)

Computational study on new natural compound agonists of stimulator of interferon genes (STING)
por: Zhong, Sheng, et al.
Publicado: (2019)

A Non-Nucleotide STING Agonist MSA-2 Synergized with Manganese in Enhancing STING Activation to Elicit Potent Anti-RNA Virus Activity in the Cells
por: Lin, Hanrui, et al.
Publicado: (2023)

417 A CTS Team Approach to Developing an Effective Vaccine for Non-Typhoidal Salmonella
por: Emerson, Lisa E., et al.
Publicado: (2023)

STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
por: Zhang, Bo-Dou, et al.
Publicado: (2022)

Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context
por: Czapla, Justyna, et al.
Publicado: (2023)

4092 TL1 Team Approach to Investigating Host-Microbe Interactions in Cancer Using a 3D Perfusion Culture System
por: Newsome, Rachel Chantal, et al.
Publicado: (2020)

438 Platelets, Inflammation and Thrombosis in Chronic Kidney Disease
por: Jain, Nishank, et al.
Publicado: (2023)

449 Progression of silica-induced pulmonary fibrosis is arrested after selective ablation of Col1a1+ fibroblasts
por: Foster, Daniel G, et al.
Publicado: (2023)

10040 Proactive and responsive COVID-19 multidisciplinary research support through the University of Minnesota’s Clinical Research Support Center
por: Odlaug, Brian L., et al.
Publicado: (2021)

436 Novel approach for tracking interdisciplinary research productivity using institutional databases
por: Bengert, Elizabeth, et al.
Publicado: (2023)

434 Ionizing radiation acoustic imaging (iRAI) for volumetric mapping the dose deep in the liver during radiation therapy
por: Zhang, Wei, et al.
Publicado: (2023)

The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation
por: Risinger, April L, et al.
Publicado: (2014)

Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity
por: McAndrews, Kathleen M., et al.
Publicado: (2021)

Nanoparticle STING Agonist Reprograms the Bone Marrow to an Antitumor Phenotype and Protects Against Bone Destruction
por: Florian, David C., et al.
Publicado: (2023)

Toll-Like Receptor Ligands and Interferon-γ Synergize for Induction of Antitumor M1 Macrophages
por: Müller, Elisabeth, et al.
Publicado: (2017)

Building the eye care team
por: Ravilla, Thulasiraj, et al.
Publicado: (2014)

Training, certification and accreditation for eye teams
por: Golnick, Karl, et al.
Publicado: (2014)

Tips for team management
por: Thulasiraj, RD
Publicado: (2018)

Leading and managing a team
por: Kiage, Dan
Publicado: (2018)

How to ‘do’ CPD with your team (from the organisation's perspective)
por: Ramasamy, Dhivya, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k5rsc2k1q2qelh599qjfqi9tvu